Ferric carboxymaltose for patients with heart failure and iron deficiency in Italy: cost–effectiveness and budget impact
Volume: 8, Issue: 13, Pages: 1099 - 1110
Published: Oct 1, 2019
Abstract
Aim: To evaluate the cost-effectiveness of intravenous ferric carboxymaltose (FCM) versus placebo for the management of iron deficiency in patients with chronic heart failure in the Italian healthcare system and to estimate its impact on the national healthcare budget. Materials & methods: A Markov model was developed to project costs and health outcomes over 1 year, based on data from literature. Healthcare resources consumption was derived...
Paper Details
Title
Ferric carboxymaltose for patients with heart failure and iron deficiency in Italy: cost–effectiveness and budget impact
Published Date
Oct 1, 2019
Volume
8
Issue
13
Pages
1099 - 1110
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History